We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging CVS Health (CVS) This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has CVS Health (CVS - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
CVS Health is a member of our Medical group, which includes 996 different companies and currently sits at #7 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. CVS Health is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for CVS' full-year earnings has moved 4% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, CVS has gained about 51.8% so far this year. At the same time, Medical stocks have lost an average of 3.9%. This means that CVS Health is outperforming the sector as a whole this year.
Another Medical stock, which has outperformed the sector so far this year, is Agenus (AGEN - Free Report) . The stock has returned 79.2% year-to-date.
Over the past three months, Agenus' consensus EPS estimate for the current year has increased 124.2%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, CVS Health belongs to the Medical Services industry, which includes 58 individual stocks and currently sits at #60 in the Zacks Industry Rank. This group has gained an average of 0.3% so far this year, so CVS is performing better in this area.
On the other hand, Agenus belongs to the Medical - Biomedical and Genetics industry. This 501-stock industry is currently ranked #83. The industry has moved -3.2% year to date.
Investors interested in the Medical sector may want to keep a close eye on CVS Health and Agenus as they attempt to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging CVS Health (CVS) This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has CVS Health (CVS - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
CVS Health is a member of our Medical group, which includes 996 different companies and currently sits at #7 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. CVS Health is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for CVS' full-year earnings has moved 4% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, CVS has gained about 51.8% so far this year. At the same time, Medical stocks have lost an average of 3.9%. This means that CVS Health is outperforming the sector as a whole this year.
Another Medical stock, which has outperformed the sector so far this year, is Agenus (AGEN - Free Report) . The stock has returned 79.2% year-to-date.
Over the past three months, Agenus' consensus EPS estimate for the current year has increased 124.2%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, CVS Health belongs to the Medical Services industry, which includes 58 individual stocks and currently sits at #60 in the Zacks Industry Rank. This group has gained an average of 0.3% so far this year, so CVS is performing better in this area.
On the other hand, Agenus belongs to the Medical - Biomedical and Genetics industry. This 501-stock industry is currently ranked #83. The industry has moved -3.2% year to date.
Investors interested in the Medical sector may want to keep a close eye on CVS Health and Agenus as they attempt to continue their solid performance.